SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway

Exp Cell Res. 2013 Jul 15;319(12):1796-1803. doi: 10.1016/j.yexcr.2013.03.030. Epub 2013 Apr 6.

Abstract

Stromal cell-derived factor-1 (SDF-1) is a chemokine and plays an important role in cell migration, whereas its role in diabetic nephropathy has not been illustrated distinctly. We hypothesized that SDF-1α may have an effect on extracellular matrix (ECM) accumulations in mesangial cells exposed to transforming growth factor-β1 (TGF-β1) or high glucose in vitro. The exogenous SDF-1α was added into rat mesangial cells incubated with TGF-β1 or high glucose in the medium. The expression of fibronectin (FN) was quantitated by real-time RT-PCR, and the change of Akt and Smad3 measured by western blotting. SDF-1α, its receptor C-X-C chemokine receptor type 4 (CXCR4) and FN mRNA were expressed in rat mesangial cells. Both TGF-β1 and high glucose raised the mRNA expressions of CXCR4 and FN in the cells. SDF-1α inhibited the elevated FN mRNA expression induced by TGF-β1 and high glucose through CXCR4 and PI3K/Akt signaling pathway, as the effect of SDF-1α was reversed by CXCR4 antagonist AMD3100 and PI3K inhibitor LY294002. Correspondingly, TGF-β1 induced Smad3 phosphorylation was suppressed when PI3K/Akt signaling pathway was activated by SDF-1α. Based on these findings, we conclude that SDF-1α ameliorates TGF-β1/high glucose induced ECM accumulations in mesangial cells, which may mediate through PI3K/Akt pathway. This novel mechanism may bring a new insight to our understandings of diabetic nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzylamines
  • Cells, Cultured
  • Chemokine CXCL12 / pharmacology*
  • Chromones / pharmacology
  • Cyclams
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / metabolism
  • Fibronectins / genetics
  • Fibronectins / metabolism*
  • Glucose / pharmacology*
  • Heterocyclic Compounds / pharmacology
  • Mesangial Cells / drug effects
  • Mesangial Cells / enzymology
  • Mesangial Cells / metabolism*
  • Morpholines / pharmacology
  • Oncogene Protein v-akt / genetics
  • Oncogene Protein v-akt / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Rats
  • Receptors, CXCR4 / antagonists & inhibitors
  • Receptors, CXCR4 / genetics
  • Receptors, CXCR4 / metabolism
  • Signal Transduction
  • Smad3 Protein / genetics
  • Smad3 Protein / metabolism
  • Transcription, Genetic / drug effects
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • Benzylamines
  • Chemokine CXCL12
  • Chromones
  • Cxcr4 protein, rat
  • Cyclams
  • Fibronectins
  • Heterocyclic Compounds
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, CXCR4
  • Smad3 Protein
  • Smad3 protein, rat
  • Transforming Growth Factor beta1
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Oncogene Protein v-akt
  • Glucose
  • plerixafor